To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Liver Cancer

Ghassan K. Abou-Alfa, MD, shares his excitement over the use of immunotherapy for liver cancer in 2018, and highlights research initiatives that are studying its potential in combination with other therapies.
Ghassan K. Abou-Alfa, MD, advises patients on what to expect from treatment with immunotherapy, including how your doctor monitors treatment response and manages adverse effects.
Ghassan K. Abou-Alfa, MD, explains how immunotherapy works in liver cancer and discusses the patient and disease characteristics that determine who is most likely to respond.
Ghassan K. Abou-Alfa, MD, highlights novel treatment approaches, such as immunotherapy, that are used in patients whose liver cancer has spread.
Ghassan K. Abou-Alfa, MD, discusses the challenges associated with treating liver cancer and highlights the various therapies used in the management of the disease.
Beth Fand Incollingo
People treated for liver cancer at an inner-city hospital experienced better survival odds if they had private health insurance, and also if they were married, according to the results of a recent study that considered how socioeconomic factors affect health outcomes for those with the disease.
Gina Columbus
The liver cancer treatment field has remained stagnant for years, but new agents are destined to enter the field in the near future, Ghassan K. Abou-Alfa, M.D., says.
Kristie L. Kahl
Blue Faery, the Adrienne Wilson Liver Cancer Association, is a nonprofit corporation founded in 2002, with the intent to prevent, treat and cure primary liver cancer – particularly HCC – through research, education and advocacy. Its name, inspired by Adrienne, has a unique background.
Christin L. Melton, E.L.S.
A panel of international oncology experts recently met to exchange thoughts on developments in the field of hepatocellular carcinoma (HCC), the most common form of liver cancer. They discussed screening and staging issues, treatment of advanced HCC and results of recent clinical trials.
Ghassan K. Abou-Alfa, M.D.
Can local and systemic therapies be combined to treat liver cancer?

Sign In

Not a member? Sign up now!
Continue without login

Sign Up

In Treatment

Maintenance/Hormone Treatment

Out of Treatment


Healthcare Professional

Not Applicable